Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Cartner, Agnes M.a | Conry, Robert M.a; | Safavy, Ahmadb | Khazaeli, M.B.a | Sumerel, Lucretia A.a | LoBuglio, Albert F.a
Affiliations: [a] Departments of Medicine Oncology, University of Alabama at Birmingham, Comprehensive Cancer Center, Birmingham, Alabama, USA | [b] Departments of Radiation Oncology, University of Alabama at Birmingham, Comprehensive Cancer Center, Birmingham, Alabama, USA
Note: [] Address reprint requests to Dr. Robert M. Conry, University of Alabama at Birmingham, Comprehensive Cancer Center, L.B. Wallace Tumor Institute 249, 1824 Sixth Avenue South, Birmingham, AL 35294-3300, USA.
Abstract: Clinical trials with genetically engineered chimeric mouse/human monoclonal antibodies have demonstrated that mouse variable regions differ dramatically in their degree of immunogenicity. These observations led us to search for an animal model that could predict mouse variable region (V region) immunogenicity prior to human clinical trials. We selected monoclonal antibodies 17-1A and B72.3 for study because human trials have demonstrated the very low immunogenicity of the mouse 17-1A V region and the high immunogenicity of the mouse B72.3 V region. Random-bred New Zealand white rabbits were injected intravenously with mouse 17-1A, B72.3, or both using a dose and schedule comparable to human trials. After initial injection only two of ten rabbits developed an antibody response to mouse 17-1A, while all five animals receiving a second injection developed antibody that was entirely mouse constant region-specific. On the other hand, nine of ten rabbits demonstrated an antibody response to initial infusion of mouse B72.3 that was greater than 90% specific for the complementarity-determining region components of the V regions. Competitive inhibition with isolated heavy and light chains demonstrated specificity for heavy or light chains (approximately 60%) or a requirement for both (40%). Thus, as in humans, the V region of 17-1A elicited little or no immune response in rabbits, while the V region of B72.3 was highly immunogenic. The observation that random-bred rabbits mimic the intensity and specificity of the human immune response to these two mouse V regions suggests that this animal model could be used to identify mouse monoclonals with V regions of low immunogenicity that would be good candidates for genetically engineered chimeric antibodies.
Keywords: monoclonal antibodies, immune response, rabbit, antibody
DOI: 10.3233/HAB-1993-4403
Journal: Human Antibodies, vol. 4, no. 4, pp. 174-180, 1993
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]